Osaka, Japan

Yuko Uegaki

This inventor holds 1 USPTO granted patent. Top assignee: Fujimoto Co., Ltd.. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuko Uegaki: Innovator in Thiazolidin-4-One Derivatives

Introduction

Yuko Uegaki is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of chemistry, particularly with his work on thiazolidin-4-one derivatives. His innovative approach has led to the development of a unique patent that showcases his expertise and creativity.

Latest Patents

Yuko Uegaki holds a patent for 2-(N-cyanoimino)thiazolidin-4-one derivatives. This invention reflects his dedication to advancing chemical compounds and their applications. The patent highlights his ability to create novel solutions that can potentially impact various industries.

Career Highlights

Uegaki is currently employed at Fujimoto Co., Ltd., where he continues to explore new ideas and innovations. His work at the company has allowed him to collaborate with other talented professionals in the field. His career is marked by a commitment to research and development, contributing to the growth of his organization.

Collaborations

Yuko Uegaki has worked alongside notable colleagues such as Fumio Yoneda and Mayumi Watanabe. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise. Together, they strive to push the boundaries of innovation in their respective fields.

Conclusion

Yuko Uegaki is a distinguished inventor whose work on thiazolidin-4-one derivatives exemplifies his innovative spirit. His contributions to Fujimoto Co., Ltd. and collaborations with esteemed colleagues further enhance his impact in the field of chemistry. Uegaki's dedication to innovation continues to inspire future advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…